Investigation of the Structure Requirement for 5-HT6 Binding Affinity of Arylsulfonyl Derivatives: A Computational Study

作者: Ming Hao , Yan Li , Hanqing Li , Shuwei Zhang

DOI: 10.3390/IJMS12085011

关键词: Steric effectsComputational chemistryBinding siteProtein structureChemistryHydrogen bondQuantitative structure–activity relationshipMoleculeMolecular dynamicsMolecular Docking Simulation

摘要: 5-HT6 receptor has been implicated in a series of diseases including anxiety, depression, schizophrenia and cognitive dysfunctions. ligands have reported to play significant role the treatment for central nervous system (CNS) diseases. Presently, large 223 were studied using combinational method by 3D-QSAR, molecular docking dynamics calculations further improvement potency. The optimal 3D models exhibit satisfying statistical results with r2ncv, q2 values 0.85 0.50 CoMFA, 0.81 0.53 CoMSIA, respectively. Their predictive powers validated external test set, showing r2pred 0.71 0.76. contour maps also provide visual representation contributions steric, electrostatic, hydrophobic hydrogen bond fields as well prospective binding models. In addition, agreement between simulation proves rationality developed These results, we hope, may be helpful designing novel potential ligands.

参考文章(48)
Ronald C. Bernotas, Schuyler Antane, Rajesh Shenoy, Van-Duc Le, Ping Chen, Boyd L. Harrison, Albert J. Robichaud, Guo Ming Zhang, Deborah Smith, Lee E. Schechter, 3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT6 receptor modulators Bioorganic & Medicinal Chemistry Letters. ,vol. 20, pp. 1657- 1660 ,(2010) , 10.1016/J.BMCL.2010.01.073
Frank G. Boess, Claus Riemer, Michael Bös, Jane Bentley, Anne Bourson, Andrew J. Sleight, The 5-Hydroxytryptamine6 Receptor-Selective radioligand [3H]Ro 63–0563 Labels 5-Hydroxytryptamine Receptor Binding Sites in Rat and Porcine Striatum Molecular Pharmacology. ,vol. 54, pp. 577- 583 ,(1998) , 10.1124/MOL.54.3.577
Steven M Bromidge, Anthony M Brown, Stephen E Clarke, Kathy Dodgson, Tracey Gager, Helen L Grassam, Phil M Jeffrey, Graham F Joiner, Frank D King, Derek N Middlemiss, Stephen F Moss, Helen Newman, Graham Riley, Carol Routledge, Paul Wyman, None, 5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist. Journal of Medicinal Chemistry. ,vol. 42, pp. 202- 205 ,(1999) , 10.1021/JM980532E
Mohamed Diwan M. AbdulHameed, Adel Hamza, Junjun Liu, Chang-Guo Zhan, Combined 3D-QSAR Modeling and Molecular Docking Study on Indolinone Derivatives as Inhibitors of 3-Phosphoinositide-Dependent Protein Kinase-1 Journal of Chemical Information and Modeling. ,vol. 48, pp. 1760- 1772 ,(2008) , 10.1021/CI800147V
B.K. Sharma, P. Singh, K. Sarbhai, Y.S. Prabhakar, A quantitative structure-activity relationship study on serotonin 5-HT6 receptor ligands: indolyl and piperidinyl sulphonamides Sar and Qsar in Environmental Research. ,vol. 21, pp. 369- 388 ,(2010) , 10.1080/10629361003773997
Serdar Durdagi, Manthos G. Papadopoulos, Panagiotis G. Zoumpoulakis, Catherine Koukoulitsa, Thomas Mavromoustakos, A computational study on cannabinoid receptors and potent bioactive cannabinoid ligands: homology modeling, docking, de novo drug design and molecular dynamics analysis. Molecular Diversity. ,vol. 14, pp. 257- 276 ,(2010) , 10.1007/S11030-009-9166-4
Kevin G. Liu, Jennifer R. Lo, Thomas A. Comery, Guo Ming Zhang, Jean Y. Zhang, Dianne M. Kowal, Deborah L. Smith, Li Di, Edward H. Kerns, Lee E. Schechter, Albert J. Robichaud, Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands. Bioorganic & Medicinal Chemistry Letters. ,vol. 19, pp. 3214- 3216 ,(2009) , 10.1016/J.BMCL.2009.04.108
H.J.C. Berendsen, D. van der Spoel, R. van Drunen, GROMACS: A message-passing parallel molecular dynamics implementation Computer Physics Communications. ,vol. 91, pp. 43- 56 ,(1995) , 10.1016/0010-4655(95)00042-E
Alexander Hillisch, Luis Felipe Pineda, Rolf Hilgenfeld, Utility of homology models in the drug discovery process. Drug Discovery Today. ,vol. 9, pp. 659- 669 ,(2004) , 10.1016/S1359-6446(04)03196-4